| 丹参川芎注射液治疗冠心病150例疗效观察 |
| |
| 引用本文： | 朱家勤,艾芬. 丹参川芎注射液治疗冠心病150例疗效观察[J]. 世界临床药物, 2008, 29(4): 232-234 |
| |
| 作者姓名： | 朱家勤 艾芬 |
| |
| 作者单位： | 武汉市中心医院药剂科;武汉市中心医院药剂科 |
| |
| 摘 要： | 目的:观察丹参川芎注射液治疗冠心病的疗效.方法:150例患者随机分为两组,对照组75例,接受单纯常规治疗包括卧床休息、吸氧以及应用硝酸酯类、肠溶阿司匹林、β受体阻断剂、钙拮抗剂、血管紧张素转化酶抑制剂(ACEI)或血管紧张素Ⅱ受体阻断剂(ARB)等药物治疗;试验组75例,在常规治疗基础上加用丹参川芎注射液10mL,加入5%葡萄糖或生理盐水250mL静脉滴注,一日1次,2周为一疗程,观察比较接受两个疗程治疗后的组间心绞痛、急性心肌梗死及心力衰竭等病症的改善情况.结果:试验组临床总有效率明显优于对照组(P＜0.05).结论:丹参川芎注射液治疗冠心痛疗效确切,不良反应少,值得临床推广.
|
| 关 键 词： | 冠心病 丹参素 川芎嗪 疗效观察 |
| 文章编号： | 1672-9188(2008)04-232-03 |
| 修稿时间： | 2008-02-28 |
The Efficacy Observation of Salvia Miltiorriza and Ligustrazine Injection for Coronary Artery Disease in 150 Cases |
| |
| Zhu Jia-Qing,Ai Fen. The Efficacy Observation of Salvia Miltiorriza and Ligustrazine Injection for Coronary Artery Disease in 150 Cases[J]. WORLD CLINICAL DRUGS, 2008, 29(4): 232-234 |
| |
| Authors: | Zhu Jia-Qing Ai Fen |
| |
| Affiliation: | Zhu Jia-Qing Ai Fen (Department of Medicament,the Central Hospital of Wuhan,Wuhan) |
| |
| Abstract: | Objective To observe the effect of salvia miltiorriza and ligustrazine injection in treatment of coronary artery disease(CAD).Methods 150 patients with CAD were randomly into trial group and control group.The patients in the control group(75 cases)were administrated with routine treatment such as sorbitrate,aspirin,ACEI and ARB,while those in the test group(75cases)were administrated with salvia miltiorriza and ligustrazine injection in addition to the routine drugs. Result The total effective rate in the t... |
| |
| Keywords: | Coronary Artery Disease salvia miltiorriza ligustrazine efficacy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
